Corcept Therapeutics (CORT) P/E (2012 - 2026)
Corcept Therapeutics (CORT) P/E from Dec 31, 2012 to Jul 21, 2026. The TTM Corcept Therapeutics (CORT) P/E is 227.27. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Corcept Therapeutics (CORT)
| Year | P/E | Change |
|---|---|---|
| 2026 | 227.27 | +671.72% |
| 2025 | 29.45 | -19.43% |
| 2024 | 36.55 | +17.93% |
| 2023 | 31.00 | +61.65% |
| 2022 | 19.18 | -14.87% |
| 2021 | 22.53 | -20.18% |
| 2020 | 28.22 | +67.98% |
| 2019 | 16.80 | -26.63% |
| 2018 | 22.90 | -60.46% |
| 2017 | 57.92 | -67.45% |
| 2016 | 177.93 | -312.68% |
| 2015 | -83.66 | +766.73% |
| 2014 | -9.65 | +38.60% |
| 2013 | -6.96 | -45.74% |
| 2012 | -12.84 | N/A |
Comparison Corcept Therapeutics (CORT) P/E with competitors
Corcept Therapeutics (CORT) P/E is 227.27.